Return to search

Synthetic approaches to c-ring unsaturated DNA cross-linking pyrrolo[2,1-c][1,4]benzodiazepine dimers

The pyrrolo[2,1-c][1,4]benzodiazepines (PBDs) are a diverse group of antitumour antibiotics in which there has been growing interest over the past 30 years. These compounds bind covalently within the minor groove of DNA via the formation of an aminal bond between the N10-C11 imine functionality of the PBD and the exocyclic C2-NH2 of a guanine base, resulting in the inhibition of processes including DNA replication and transcription, thus leading to cell death. PBD `dimers' have the ability to form irreversible interstrand cross-links with DNA. One example, DSB-120, has been shown to recognise six base pairs compared to the monomer DC-81 that recognises only three. A second example, SJG-136, has unsaturation at the C2 position and is cytotoxic at the picomolar level in glutathione-rich cell lines resistant to a number of agents including DSB-120. The major part of this project concerns the synthesis of novel PBD dimers specifically designed to investigate the effect of sp1 hybridisation at the C2 position of the molecule. One problem has been that only small amounts of PBD dimers were previously available through the original synthetic routes. Through this project, three new synthetic methodologies have been devised to produce two novel PBD dimers KEC-570 and KEC-5130, as well as the known PBD dimers SJG-136 and DSB-120. These syntheses utilise novel cyclisation procedures that involve fewer steps than existing synthetic methods and afford cleaner products in higher yields and on a larger scale. This has allowed, for the first time, a full pharmacological evaluation of these molecules. KEC-570 has been shown to form interstrand DNA cross-links and to be cytotoxic in three human carcinoma cell lines. Presently, both KEC-570 and DSB-120 are being evaluated across the standard panel of tumour cell lines at the National Cancer Institute. SJG-136 has proved successful in the NCI's Hollow Fibre assay and has progressed to in vivo xenograft assays at the NCI.

Identiferoai:union.ndltd.org:bl.uk/oai:ethos.bl.uk:368745
Date January 1998
CreatorsCorcoran, Kathryn Elizabeth
PublisherUniversity of Portsmouth
Source SetsEthos UK
Detected LanguageEnglish
TypeElectronic Thesis or Dissertation

Page generated in 0.0016 seconds